Compound ID | 266
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | DNA synthesis inhibitor. DNA minor groove binder; alkylator |
| Target Pathogen: | Active against Staphylococcus sp. and streptococci |
| Description: | Natural product from an actinomycete strain; an anthraquinone-type antibiotic |
| Institute where first reported: | Abbott Laboratories (AbbieVie USA) |
| Year first mentioned: | 1989 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| Reason dropped: | Probably highly cytotoxic |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/148125 |
| Guide to Pharmacology: | Altromycin B |
| Citations: |
|